@prefix biopax:  <http://www.biopax.org/release/biopax-level3.owl#> .
@prefix cito:    <http://purl.org/spar/cito/> .
@prefix dc:      <http://purl.org/dc/elements/1.1/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix foaf:    <http://xmlns.com/foaf/0.1/> .
@prefix freq:    <http://purl.org/cld/freq/> .
@prefix gpml:    <http://vocabularies.wikipathways.org/gpml#> .
@prefix owl:     <http://www.w3.org/2002/07/owl#> .
@prefix pav:     <http://purl.org/pav/> .
@prefix prov:    <http://www.w3.org/ns/prov#> .
@prefix rdf:     <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs:    <http://www.w3.org/2000/01/rdf-schema#> .
@prefix skos:    <http://www.w3.org/2004/02/skos/core#> .
@prefix void:    <http://rdfs.org/ns/void#> .
@prefix wp:      <http://vocabularies.wikipathways.org/wp#> .
@prefix wprdf:   <http://rdf.wikipathways.org/> .
@prefix xsd:     <http://www.w3.org/2001/XMLSchema#> .

<http://rdf.wikipathways.org/Pathway/WP5035/WP5035_rWP5035_r125622/WP/Interaction/id4ce306be>
        rdf:type  wp:Interaction .

<https://identifiers.org/aop.events/1496>
        rdf:type            wp:DataNode;
        rdfs:label          "Increased, secretion of proinflammatory and profibrotic mediators";
        dc:identifier       <https://identifiers.org/aop.events/1496>;
        dc:source           "AOP-Wiki KE";
        dcterms:identifier  "1496";
        wp:isAbout          <http://rdf.wikipathways.org/Pathway/WP5035/WP5035_rWP5035_r125622/DataNode/b99c0>;
        foaf:page           <https://aopwiki.org/events/1496> .

<https://identifiers.org/aop.events/68>
        rdf:type            wp:DataNode;
        rdfs:label          "KE68: Collagen Accumulation";
        dc:identifier       <https://identifiers.org/aop.events/68>;
        dc:source           "AOP-Wiki KE";
        dcterms:identifier  "68";
        wp:isAbout          <http://rdf.wikipathways.org/Pathway/WP5035/WP5035_rWP5035_r125622/DataNode/ca74c>;
        foaf:page           <https://aopwiki.org/events/68> .

<https://identifiers.org/wikipathways/WP5068>
        rdf:type            wp:Pathway , wp:DataNode;
        rdfs:label          "Bradykinin signaling network";
        dc:identifier       <https://identifiers.org/wikipathways/WP5068>;
        dc:source           "WikiPathways";
        dcterms:identifier  "WP5068";
        wp:isAbout          <http://rdf.wikipathways.org/Pathway/WP5035/WP5035_rWP5035_r125622/DataNode/b2397>;
        foaf:page           <https://www.wikipathways.org/instance/WP5068> .

<http://rdf.wikipathways.org/Pathway/WP5035/WP5035_rWP5035_r125622/WP/Interaction/idb5f28f5a>
        rdf:type  wp:Interaction .

<http://rdf.wikipathways.org/Pathway/WP5035/WP5035_rWP5035_r125622/WP/Interaction/idd87eb1e>
        rdf:type  wp:Interaction .

<https://identifiers.org/wikipathways/WP2725>
        rdf:type            wp:Pathway , wp:DataNode;
        rdfs:label          "Collagen biosynthesis and modifying enzymes";
        dc:identifier       <https://identifiers.org/wikipathways/WP2725>;
        dc:source           "WikiPathways";
        dcterms:identifier  "WP2725";
        wp:isAbout          <http://rdf.wikipathways.org/Pathway/WP5035/WP5035_rWP5035_r125622/DataNode/fe190>;
        foaf:page           <https://www.wikipathways.org/instance/WP2725> .

<http://rdf.wikipathways.org/Pathway/WP5035/WP5035_rWP5035_r125622/WP/Interaction/id9a960468>
        rdf:type  wp:Interaction .

<https://identifiers.org/wikipathways/WP5088>
        rdf:type            wp:Pathway , wp:DataNode;
        rdfs:label          "Prostaglandin signaling";
        dc:identifier       <https://identifiers.org/wikipathways/WP5088>;
        dc:source           "WikiPathways";
        dcterms:identifier  "WP5088";
        wp:isAbout          <http://rdf.wikipathways.org/Pathway/WP5035/WP5035_rWP5035_r125622/DataNode/a550b>;
        foaf:page           <https://www.wikipathways.org/instance/WP5088> .

<https://identifiers.org/aop.events/1851>
        rdf:type            wp:DataNode;
        rdfs:label          "Binding of agonist, Angiotensin II receptor type 1 receptor (AT1R)";
        dc:identifier       <https://identifiers.org/aop.events/1851>;
        dc:source           "AOP-Wiki KE";
        dcterms:identifier  "1851";
        wp:isAbout          <http://rdf.wikipathways.org/Pathway/WP5035/WP5035_rWP5035_r125622/DataNode/e5b8a>;
        foaf:page           <https://aopwiki.org/events/1851> .

<https://identifiers.org/aop.events/1752>
        rdf:type            wp:DataNode;
        rdfs:label          "KE1752: Increased Angiotensin II";
        dc:identifier       <https://identifiers.org/aop.events/1752>;
        dc:source           "AOP-Wiki KE";
        dcterms:identifier  "1752";
        wp:isAbout          <http://rdf.wikipathways.org/Pathway/WP5035/WP5035_rWP5035_r125622/DataNode/c9e7f>;
        foaf:page           <https://aopwiki.org/events/1752> .

<https://identifiers.org/wikipathways/WP4756>
        rdf:type            wp:Pathway , wp:DataNode;
        rdfs:label          "Renin Angiotensin Aldosterone System";
        dc:identifier       <https://identifiers.org/wikipathways/WP4756>;
        dc:source           "WikiPathways";
        dcterms:identifier  "WP4756";
        wp:isAbout          <http://rdf.wikipathways.org/Pathway/WP5035/WP5035_rWP5035_r125622/DataNode/d25dd>;
        foaf:page           <https://www.wikipathways.org/instance/WP4756> .

<https://identifiers.org/aop.events/1743>
        rdf:type            wp:DataNode;
        rdfs:label          "KE1743: Increased plasma Angiotensin II";
        dc:identifier       <https://identifiers.org/aop.events/1743>;
        dc:source           "AOP-Wiki KE";
        dcterms:identifier  "1743";
        wp:isAbout          <http://rdf.wikipathways.org/Pathway/WP5035/WP5035_rWP5035_r125622/DataNode/e9df7>;
        foaf:page           <https://aopwiki.org/events/1743> .

<https://identifiers.org/aop.events/1867>
        rdf:type            wp:DataNode;
        rdfs:label          "Bradykinin system, hyperactivated";
        dc:identifier       <https://identifiers.org/aop.events/1867>;
        dc:source           "AOP-Wiki KE";
        dcterms:identifier  "1867";
        wp:isAbout          <http://rdf.wikipathways.org/Pathway/WP5035/WP5035_rWP5035_r125622/DataNode/eb778>;
        foaf:page           <https://aopwiki.org/events/1867> .

<http://rdf.wikipathways.org/Pathway/WP5035/WP5035_rWP5035_r125622/WP/Interaction/ida6ac42e8>
        rdf:type  wp:Interaction .

<http://rdf.wikipathways.org/Pathway/WP5035/WP5035_rWP5035_r125622/WP/Interaction/idf1a7869a>
        rdf:type  wp:Interaction .

<https://identifiers.org/wikipathways/WP5035/WP5035_rWP5035_r125622>
        rdf:type             wp:Pathway , skos:Collection;
        dc:identifier        <https://identifiers.org/wikipathways/WP5035/WP5035>;
        dc:source            "WikiPathways";
        dc:title             "ACE2 inhibition leads to pulmonary fibrosis"@en;
        dcterms:description  "This AOP outlines how ACE-2 plays a detrimental role in causing fibrotic damage to the lung by influencing various factors such as fibrogenic components, proinflammatory cytokines, and a lack of oxygen. When the activity of ACE2 is suppressed, the conversion of Ang II into Ang-(1-7) is not properly facilitated. Consequently, the levels of proinflammatory Ang II rise, while the levels of anti-inflammatory Ang-(1-7) decrease. Notably, ACE2 inhibition has been observed to raise the levels of Ang II peptides, which are a ligand for the type 1 angiotensin receptor (AT1R). This phenomenon is considered a significant risk factor for lung fibrosis, vasoconstriction, endothelial dysfunction, and cell death.";
        dcterms:identifier   "WP5035/WP5035";
        wp:isAbout           <http://rdf.wikipathways.org/Pathway/WP5035/WP5035_rWP5035_r125622>;
        wp:organismName      "Homo sapiens";
        foaf:page            <http://www.wikipathways.org/instance/WP5035/WP5035_rWP5035_r125622> .

<http://rdf.wikipathways.org/Pathway/WP5035/WP5035_rWP5035_r125622/WP/Interaction/id570aed5e>
        rdf:type  wp:Interaction .

<https://identifiers.org/wikipathways/WP5036>
        rdf:type            wp:Pathway , wp:DataNode;
        rdfs:label          "Angiotensin II receptor type 1 pathway";
        dc:identifier       <https://identifiers.org/wikipathways/WP5036>;
        dc:source           "WikiPathways";
        dcterms:identifier  "WP5036";
        wp:isAbout          <http://rdf.wikipathways.org/Pathway/WP5035/WP5035_rWP5035_r125622/DataNode/f1d0a>;
        foaf:page           <https://www.wikipathways.org/instance/WP5036> .

<https://identifiers.org/wikipathways/WP5089>
        rdf:type            wp:Pathway , wp:DataNode;
        rdfs:label          "Kinin-Kallikrein Pathway";
        dc:identifier       <https://identifiers.org/wikipathways/WP5089>;
        dc:source           "WikiPathways";
        dcterms:identifier  "WP5089";
        wp:isAbout          <http://rdf.wikipathways.org/Pathway/WP5035/WP5035_rWP5035_r125622/DataNode/dce22>;
        foaf:page           <https://www.wikipathways.org/instance/WP5089> .

<https://identifiers.org/wikipathways/WP4562>
        rdf:type            wp:Pathway , wp:DataNode;
        rdfs:label          "NF-KB pathway";
        dc:identifier       <https://identifiers.org/wikipathways/WP4562>;
        dc:source           "WikiPathways";
        dcterms:identifier  "WP4562";
        wp:isAbout          <http://rdf.wikipathways.org/Pathway/WP5035/WP5035_rWP5035_r125622/DataNode/f5a92>;
        foaf:page           <https://www.wikipathways.org/instance/WP4562> .

<https://identifiers.org/aop.events/1276>
        rdf:type            wp:DataNode;
        rdfs:label          "KE1276: Lung Fibrosis";
        dc:identifier       <https://identifiers.org/aop.events/1276>;
        dc:source           "AOP-Wiki KE";
        dcterms:identifier  "1276";
        wp:isAbout          <http://rdf.wikipathways.org/Pathway/WP5035/WP5035_rWP5035_r125622/DataNode/a99c1>;
        foaf:page           <https://aopwiki.org/events/1276> .

<https://identifiers.org/wikipathways/WP554>
        rdf:type            wp:Pathway , wp:DataNode;
        rdfs:label          "ACE2 inhibition";
        dc:identifier       <https://identifiers.org/wikipathways/WP554>;
        dc:source           "WikiPathways";
        dcterms:identifier  "WP554";
        wp:isAbout          <http://rdf.wikipathways.org/Pathway/WP5035/WP5035_rWP5035_r125622/DataNode/a18ad>;
        foaf:page           <https://www.wikipathways.org/instance/WP554> .

<https://identifiers.org/wikipathways/WP408>
        rdf:type            wp:Pathway , wp:DataNode;
        rdfs:label          "Oxidative stress";
        dc:identifier       <https://identifiers.org/wikipathways/WP408>;
        dc:source           "WikiPathways";
        dcterms:identifier  "WP408";
        wp:isAbout          <http://rdf.wikipathways.org/Pathway/WP5035/WP5035_rWP5035_r125622/DataNode/f37f8>;
        foaf:page           <https://www.wikipathways.org/instance/WP408> .

<http://rdf.wikipathways.org/Pathway/WP5035/WP5035_rWP5035_r125622/WP/Interaction/ed7be>
        rdf:type  wp:Interaction .

<https://identifiers.org/aop.events/1115>
        rdf:type            wp:DataNode;
        rdfs:label          "Increased, Reactive oxygen species";
        dc:identifier       <https://identifiers.org/aop.events/1115>;
        dc:source           "AOP-Wiki KE";
        dcterms:identifier  "1115";
        wp:isAbout          <http://rdf.wikipathways.org/Pathway/WP5035/WP5035_rWP5035_r125622/DataNode/cf66e>;
        foaf:page           <https://aopwiki.org/events/1115> .

<http://rdf.wikipathways.org/Pathway/WP5035/WP5035_rWP5035_r125622/WP/Interaction/id977e17f7>
        rdf:type  wp:Interaction .

<https://identifiers.org/aop.events/1172>
        rdf:type            wp:DataNode;
        rdfs:label          "Increase activation, Nuclear factor kappa B (NF-kB)";
        dc:identifier       <https://identifiers.org/aop.events/1172>;
        dc:source           "AOP-Wiki KE";
        dcterms:identifier  "1172";
        wp:isAbout          <http://rdf.wikipathways.org/Pathway/WP5035/WP5035_rWP5035_r125622/DataNode/ba262>;
        foaf:page           <https://aopwiki.org/events/1172> .

<http://rdf.wikipathways.org/Pathway/WP5035/WP5035_rWP5035_r125622/WP/Interaction/id1552b68>
        rdf:type  wp:Interaction .

<http://rdf.wikipathways.org/Pathway/WP5035/WP5035_rWP5035_r125622/WP/Interaction/idbc9182bd>
        rdf:type  wp:Interaction .

<https://identifiers.org/wikipathways/WP2729>
        rdf:type            wp:Pathway , wp:DataNode;
        rdfs:label          "Metabolism of Angiotensinogen to Angiotensins";
        dc:identifier       <https://identifiers.org/wikipathways/WP2729>;
        dc:source           "WikiPathways";
        dcterms:identifier  "WP2729";
        wp:isAbout          <http://rdf.wikipathways.org/Pathway/WP5035/WP5035_rWP5035_r125622/DataNode/c1af7>;
        foaf:page           <https://www.wikipathways.org/instance/WP2729> .

<https://identifiers.org/aop.events/1740>
        rdf:type            wp:DataNode;
        rdfs:label          "KE1740: ACE2 inhibition";
        dc:identifier       <https://identifiers.org/aop.events/1740>;
        dc:source           "AOP-Wiki KE";
        dcterms:identifier  "1740";
        wp:isAbout          <http://rdf.wikipathways.org/Pathway/WP5035/WP5035_rWP5035_r125622/DataNode/f0a9a>;
        foaf:page           <https://aopwiki.org/events/1740> .

<https://identifiers.org/wikipathways/WP5095>
        rdf:type            wp:Pathway , wp:DataNode;
        rdfs:label          "Overview of proinflammatory and profibrotic mediators";
        dc:identifier       <https://identifiers.org/wikipathways/WP5095>;
        dc:source           "WikiPathways";
        dcterms:identifier  "WP5095";
        wp:isAbout          <http://rdf.wikipathways.org/Pathway/WP5035/WP5035_rWP5035_r125622/DataNode/db290>;
        foaf:page           <https://www.wikipathways.org/instance/WP5095> .
